ArticleCancers2022

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses.

Hendrik Ungefroren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.